Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

160
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
160
Parameters Affecting Nonlinear Elimination: Zero-Order Input, First-Order Absorption and Two-Compartment Model01:13

Parameters Affecting Nonlinear Elimination: Zero-Order Input, First-Order Absorption and Two-Compartment Model

130
Drugs administered through various routes can lead to nonlinear elimination, resulting in complex pharmacokinetic behaviors crucial to understanding efficacious drug dosing.
When a drug is administered through a constant intravenous infusion and eliminated via nonlinear pharmacokinetics, it follows zero-order input. For example, oral drugs undergo first-order absorption upon administration and are eliminated through nonlinear pharmacokinetics.
In the case of subcutaneously administered drugs,...
130
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

1.3K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.3K
Clearance Models: Compartment Models01:25

Clearance Models: Compartment Models

143
Clearance measures drug elimination from the central compartment, including plasma and highly perfused organs like kidneys and liver. Its calculation varies depending on pharmacokinetic models and administration routes. The one-compartment model, for instance, portrays the pharmacokinetics of polar drugs such as aminoglycoside antibiotics administered intravenously and readily excreted in urine. In this case, clearance is influenced by the terminal rate constant (λz) and the total volume...
143
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

415
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
415
Two-Compartment Open Model: IV Infusion01:15

Two-Compartment Open Model: IV Infusion

357
A two-compartment model is a vital tool in pharmacokinetics, providing an essential understanding of drug behavior, especially for those administered via zero-order intravenous infusion. This model outlines two compartments: the central compartment, where elimination occurs, and the peripheral compartment.
The model illustrates the decrease in plasma drug concentration from the central compartment with a specific equation. It shows that under steady-state conditions, the drug's input rate...
357

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reward prediction is encoded by orexin neuron activity during motivated behavior.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Association of nutritional indices with hyporesponsiveness to hypoxia-inducible factor-prolyl hydroxylase inhibitors in patients with chronic kidney disease: a single-center retrospective observational study.

BMC nephrology·2026
Same author

Distinct Effects of Nonselective Rho-Kinase Inhibitor Fasudil and Selective Rho-Kinase 2 Inhibitor KD025 on Serotonin and Dopamine Release in the Nucleus Accumbens of Mice.

Neuropsychopharmacology reports·2026
Same author

Phosphoproteomics identifies Rho-kinase-associated phospho-signaling and autophagy-associated alterations in the medial prefrontal cortex of a schizophrenia-related mouse model.

Pharmacological research·2026
Same author

On-demand GLUT3 expression augments CAR T cell metabolic fitness and antitumor efficacy in preclinical models of glioblastoma.

Science translational medicine·2026
Same author

Integration of Pharmacists' Knowledge into a Predictive Model for Teicoplanin Dose Planning.

Biological & pharmaceutical bulletin·2026

Related Experiment Video

Updated: Sep 30, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.4K

A machine learning model that emulates experts' decision making in vancomycin initial dose planning.

Tetsuo Matsuzaki1, Yoshiaki Kato1, Hiroyuki Mizoguchi1

  • 1Hospital Pharmacy, Nagoya University Graduate School of Medicine, Nagoya, Aichi, 466-8560, Japan.

Journal of Pharmacological Sciences
|March 18, 2022
PubMed
Summary

Machine learning models can predict optimal initial vancomycin doses, improving treatment for methicillin-resistant Staphylococcus aureus infections. This approach aims to match expert dosing accuracy, enhancing vancomycin therapy effectiveness and safety.

Keywords:
Initial dosing regimenMRSAMachine learningTDMVancomycin

More Related Videos

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM
13:54

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM

Published on: August 18, 2023

5.1K
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

7.0K

Related Experiment Videos

Last Updated: Sep 30, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.4K
A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM
13:54

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM

Published on: August 18, 2023

5.1K
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

7.0K

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Computational Biology

Background:

  • Vancomycin is crucial for treating methicillin-resistant Staphylococcus aureus (MRSA).
  • Therapeutic drug monitoring (TDM) is vital for vancomycin efficacy and preventing nephrotoxicity.
  • Current initial dosing relies heavily on clinician expertise due to a lack of comprehensive strategies.

Purpose of the Study:

  • To develop a machine learning (ML) model for predicting initial vancomycin dosing.
  • To integrate expert clinical knowledge into an automated dosing decision support tool.
  • To improve the accuracy and consistency of initial vancomycin dosing regimens.

Main Methods:

  • Utilized a dataset of initial vancomycin dose plans created by experienced pharmacists (experts).
  • Developed and trained a machine learning model using this expert-defined data.
  • Evaluated the ML model's predictive performance against expert performance and existing software.

Main Results:

  • The ML model achieved a target attainment rate comparable to that of human experts.
  • The model's performance was also similar to another ML model and standard vancomycin dosing software.
  • Demonstrated the feasibility of using ML to replicate expert decision-making in vancomycin dosing.

Conclusions:

  • A machine learning approach can effectively guide initial vancomycin dosing decisions.
  • This strategy offers a potential solution for optimizing vancomycin therapy, especially where expert consultations are limited.
  • The developed model aids clinicians in achieving therapeutic vancomycin concentrations, enhancing patient outcomes.